- Report
- March 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- April 2023
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2023
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 115 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2023
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2023
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
China
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
France
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Germany
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
India
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Poland
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1432EUR$1,500USD£1,199GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more